BOND-003 Study

Clinicaltrials.gov ID:
NCT04452591

CG Oncology Study ID:
Cretostimogene grenadenorepvec (CG0070)

Condition:
Non-Muscle Invasive Bladder Cancer

Contact:
Recruitment@cgoncology.com

BOND-003 Study Patient Eligibility

START

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided.

Download your Doctor Discussion Guide to help guide conversations with your health care professional:

Download

Patient Eligibility

Are you at least 18 years of age?

Yes

Are you able to walk, and are you generally able to care for yourself?

Yes

Have you been diagnosed with non-muscle invasive bladder cancer?

Yes

Have you received BCG as a treatment for bladder cancer?

Yes

After BCG treatment, have you been diagnosed with the type of bladder cancer called CIS (carcinoma in situ)?

Yes